Next Article in Journal
Prospects for the Development of Pink1 and Parkin Activators for the Treatment of Parkinson’s Disease
Next Article in Special Issue
CuS-131I-PEG Nanotheranostics-Induced “Multiple Mild-Hyperthermia” Strategy to Overcome Radio-Resistance in Lung Cancer Brachytherapy
Previous Article in Journal
Pheophorbide A–Mediated Photodynamic Therapy Potentiates Checkpoint Blockade Therapy of Tumor with Low PD–L1 Expression
Previous Article in Special Issue
Self−Assembling Anchorage of Hyaluronic Acid on the Nanoparticle Surface Confers Superiority of Triple Negative Breast Cancer Treatment
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(11), 2512; https://doi.org/10.3390/pharmaceutics14112512
Action Date Notes Link
article pdf uploaded. 18 November 2022 16:19 CET Version of Record https://www.mdpi.com/1999-4923/14/11/2512/pdf-vor
article xml file uploaded 22 November 2022 11:42 CET Original file -
article xml uploaded. 22 November 2022 11:42 CET Update https://www.mdpi.com/1999-4923/14/11/2512/xml
article pdf uploaded. 22 November 2022 11:42 CET Updated version of record https://www.mdpi.com/1999-4923/14/11/2512/pdf
article html file updated 22 November 2022 11:44 CET Original file -
article html file updated 28 February 2023 23:48 CET Update -
article html file updated 3 March 2023 21:14 CET Update https://www.mdpi.com/1999-4923/14/11/2512/html
Back to TopTop